Rotavirus vaccination in central Europe.

Each year, rotavirus (RV) infection is the leading cause of acute gastroenteritis requiring hospitalisation and of nosocomially transmitted diseases in children younger than 5 years across Central European Vaccination Awareness Group (CEVAG) countries; however, inadequate surveillance systems and lack of routine RV testing still exist in most CEVAG countries, making it difficult to accurately assess the present burden of acute RV gastroenteritis in the younger population. Furthermore, routine immunisation of infants with RV vaccines has not been implemented, and no official and uniform recommendations exist in most of the countries in these territories. The present study provides CEVAG country-specific estimates of the disease burden of RV gastroenteritis among the youngest population and presents evidence-based advice on the use of RV vaccines in the region, while providing a framework for vaccination at the national level.

[1]  C. Giaquinto,et al.  Report of the second European expert meeting on rotavirus vaccination. , 2012, Vaccine.

[2]  H. Soeorg,et al.  Group A rotavirus genotypes circulating prior to implementation of a National Immunization Program in Estonia , 2012, Human vaccines & immunotherapeutics.

[3]  J. Tate,et al.  2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis. , 2012, The Lancet. Infectious diseases.

[4]  M. Hacımustafaoğlu,et al.  Rotavirus epidemiology of children in Bursa, Turkey: a multi-centered hospital-based descriptive study. , 2011, The Turkish journal of pediatrics.

[5]  A. Nurchi,et al.  Epidemiology and prevention of rotavirus infection: an underestimated issue? , 2011, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[6]  M. Goetghebeur,et al.  Burden of rotavirus gastroenteritis in the pediatric population in Central and Eastern Europe , 2011, Human vaccines.

[7]  M. Kundi,et al.  Herd immunity after two years of the universal mass vaccination program against rotavirus gastroenteritis in Austria. , 2011, Vaccine.

[8]  M. Iturriza-Gómara,et al.  Genetic characterization of bulgarian rotavirus isolates and detection of rotavirus variants: challenges for the rotavirus vaccine program? , 2011, Journal of medical virology.

[9]  L. Cantarutti,et al.  Primary care-based surveillance to estimate the burden of rotavirus gastroenteritis among children aged less than 5 years in six European countries , 2011, European Journal of Pediatrics.

[10]  D. Raoult,et al.  The Q fever epidemic in The Netherlands: history, onset, response and reflection , 2010, Epidemiology and Infection.

[11]  T. Dallman,et al.  Rotavirus genotypes co-circulating in Europe between 2006 and 2009 as determined by EuroRotaNet, a pan-European collaborative strain surveillance network , 2010, Epidemiology and Infection.

[12]  C. Giaquinto,et al.  Recommendations for rotavirus vaccination: A worldwide perspective. , 2010, Vaccine.

[13]  M. Iturriza-Gómara,et al.  Molecular epidemiology of rotaviruses in Bulgaria: annual shift of the predominant genotype , 2010, European Journal of Clinical Microbiology & Infectious Diseases.

[14]  M. Ceyhan,et al.  Multicenter prospective study on the burden of rotavirus gastroenteritis in Turkey, 2005-2006: a hospital-based study. , 2009, The Journal of infectious diseases.

[15]  A. Steyer,et al.  Molecular epideMiology of rotaviruses during rotavirus vaccine introduction in slovenia , 2009 .

[16]  J. Kónya,et al.  [Post vaccination rotavirus surveillance in Hungary, in 2007]. , 2009, Orvosi hetilap.

[17]  J. Kónya,et al.  First detection of P[6],G9 rotaviruses in Hungary--an imported strain from India? , 2009, Journal of travel medicine.

[18]  U. Wahn,et al.  Hospital-Based Surveillance to Estimate the Burden of Rotavirus Gastroenteritis Among European Children Younger Than 5 Years of Age , 2009, Pediatrics.

[19]  Roger I Glass,et al.  Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP). , 2009, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[20]  J. Gray,et al.  Survey of rotavirus surveillance, laboratory capacity and disease burden in the eastern part of the WHO European Region. , 2008, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[21]  C. Giaquinto,et al.  European Society for Paediatric Infectious Diseases/European Society for Paediatric Gastroenterology, Hepatology, and Nutrition Evidence-Based Recommendations for Rotavirus Vaccination in Europe , 2008, Journal of pediatric gastroenterology and nutrition.

[22]  P. Šimurka,et al.  Nosocomial rotaviral gastroenteritis in paediatric departments. , 2008, Central European journal of public health.

[23]  J. Mrukowicz,et al.  The Clinical Burden of Rotavirus Disease: Retrospective Analysis of Infant and Childhood Gastroenteritis in Seven Countries in Central and Eastern Europe , 2008 .

[24]  T. Vesikari,et al.  Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study , 2007, The Lancet.

[25]  F. Ruggeri,et al.  Molecular Epidemiology of Rotavirus in Central and Southeastern Europe , 2007, Journal of Clinical Microbiology.

[26]  C. Giaquinto The paediatric burden of rotavirus disease in Europe , 2006, Epidemiology and Infection.

[27]  T. Vesikari,et al.  Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. , 2006, The New England journal of medicine.

[28]  C. Giaquinto,et al.  Nosocomial Rotavirus Infection in European Countries: A Review of the Epidemiology, Severity and Economic Burden of Hospital-Acquired Rotavirus Disease , 2006, The Pediatric infectious disease journal.

[29]  A. Steyer,et al.  The emergence of rotavirus genotype G9 in hospitalised children in Slovenia. , 2005, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[30]  H. Patural,et al.  Suivi prospectif des diarrhées nosocomiales dans 28 services de pédiatrie du quart Sud-Est de la France au cours d'un trimestre d'hiver , 2004 .

[31]  I. Yaprak,et al.  Rotavirus gastroenteritis among children under five years of age in Izmir, Turkey. , 2003, The Turkish journal of pediatrics.

[32]  S. Gelber,et al.  Hospital-acquired viral pathogens in the neonatal intensive care unit , 2002, Seminars in Perinatology.

[33]  Jacqueline E Tate,et al.  estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes : a systematic review and meta-analysis , 2011 .

[34]  R. Liausedienė,et al.  Rotavirus and norovirus infections in Lithuania, 1994-2009. , 2010 .

[35]  C. Ulmeanu,et al.  [Frequency and severity of rotavirus acute gastroenteritis hospitalized in Bucharest, Romania. Results of a case-control study]. , 2009, Bacteriologia, virusologia, parazitologia, epidemiologia.

[36]  M. Patrzałek,et al.  [The cases of rotaviral diarrhea from Kielce and Kielce district, hospitalized in Kielce Voivodeship Children Hospital in 2002-2006]. , 2008, Przeglad epidemiologiczny.

[37]  Y. Hoshino,et al.  Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine , 2005, Reviews in medical virology.

[38]  WHO report on infectious diseases. , 1999, Releve epidemiologique hebdomadaire.

[39]  J. Eskola,et al.  EUROPEAN SOCIETY FOR PAEDIATRIC INFECTIOUS DISEASES , 1991, Pediatric Research.